Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Dorinsky

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 1, 2002
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthmaDavid S Pearlman, Martha V White, Allen K Lieberman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 12, 2005
Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthmaDavid S Pearlman, David Peden, John J Condemi, et al.
Plos One|September 17, 2013
EGF-induced bronchial epithelial cells drive neutrophil chemotactic and anti-apoptotic activity in asthmaMohib Uddin, Laurie C Lau, Grégory Seumois, et al.
Thorax|June 14, 2020
Association between COPD exacerbations and lung function decline during maintenance therapyMarjan Kerkhof, Jaco Voorham, Paul Dorinsky, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 22, 2020
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function DeclineMarjan Kerkhof, Jaco Voorham, Paul Dorinsky, et al.
Advances in Therapy|March 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOSChen Wang, Ting Yang, Jian Kang, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2010
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational studyDavid Price, Richard J Martin, Neil Barnes, et al.
The Lancet. Respiratory Medicine|September 21, 2018
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trialGary T Ferguson, Klaus F Rabe, Fernando J Martinez, et al.
Respiratory Medicine|October 13, 2019
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocolKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS StudyMasakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 1, 2002
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthmaDavid S Pearlman, Martha V White, Allen K Lieberman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 12, 2005
Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthmaDavid S Pearlman, David Peden, John J Condemi, et al.
Plos One|September 17, 2013
EGF-induced bronchial epithelial cells drive neutrophil chemotactic and anti-apoptotic activity in asthmaMohib Uddin, Laurie C Lau, Grégory Seumois, et al.
Thorax|June 14, 2020
Association between COPD exacerbations and lung function decline during maintenance therapyMarjan Kerkhof, Jaco Voorham, Paul Dorinsky, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 22, 2020
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function DeclineMarjan Kerkhof, Jaco Voorham, Paul Dorinsky, et al.
Advances in Therapy|March 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOSChen Wang, Ting Yang, Jian Kang, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2010
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational studyDavid Price, Richard J Martin, Neil Barnes, et al.
The Lancet. Respiratory Medicine|September 21, 2018
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trialGary T Ferguson, Klaus F Rabe, Fernando J Martinez, et al.
Respiratory Medicine|October 13, 2019
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocolKlaus F Rabe, Fernando J Martinez, Gary T Ferguson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS StudyMasakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, et al.
Pageof 6